F-1: MEDIROM Healthcare Technologies Eyes U.S. Expansion with Proposed ADS Offering

Sentiment:

F-1 Filing


MEDIROM Healthcare Technologies is seeking to raise capital through an ADS offering to fuel working capital, acquisitions, and strategic collaborations, primarily focused on expanding its holistic health services in Japan and potentially overseas.

Delay expectedThe Digital Preventative Healthcare Segment generated a total revenue of JPY200,397 thousand (US$1,422 thousand), as compared to a total revenue of JPY386,383 thousand (US$2,742 thousand) for the year ended December 31, 2022, a decrease that we believe was primarily due to a delay in the development and release of planned products and services.
Capital raiseMEDIROM is planning a public offering of American Depositary Shares (ADS) to raise capital for expansion and general corporate purposes.We are in negotiations with a bank to obtain a loan in the principal amount of at least JPY1,400,000 thousand (US$9,935 thousand) to partially finance our planned acquisition of 70% of the equity of JGMC.
Worse than expectedThe Digital Preventative Healthcare Segment generated a total revenue of JPY200,397 thousand (US$1,422 thousand), as compared to a total revenue of JPY386,383 thousand (US$2,742 thousand) for the year ended December 31, 2022, a decrease that we believe was primarily due to a delay in the development and release of planned products and services.Revenue from our Luxury Beauty Segment was JPY567,695 thousand (US$4,029 thousand) in 2023, a decrease from JPY594,761 thousand (US$4,512 thousand) in 2022.Our Repeat Ratio was 76.4% in the half year ended June 30, 2024, a slight decrease from 77.0% in the half year ended June 30, 2023.Our Operation Ratio was 45.2% in the half year ended June 30, 2024, a slight decrease from 47.1% in the half year ended June 30, 2023.

Summary

  • MEDIROM Healthcare Technologies Inc., a Japanese holistic health services provider, has filed a Form F-1 registration statement for a proposed public offering of American Depositary Shares (ADS).
  • The company intends to use the net proceeds for working capital and general corporate purposes, including potential investments, acquisitions, and strategic collaborations.
  • MEDIROM's primary focus is to expand its customer base and develop new services, with a significant emphasis on growth within the Japanese market.
  • The company operates three main business segments: Relaxation Salon, Luxury Beauty, and Digital Preventative Healthcare (HealthTech).
  • As of June 30, 2024, the Relaxation Salon Segment had 308 locations across Japan.
  • The company's mid-term business plan aims to operate 500 salons on a system-wide basis by the end of 2028.
  • MEDIROM is also exploring opportunities to increase its presence in overseas markets, including the United States and Southeast Asia.
  • The Digital Preventative Healthcare Segment includes the Lav application for the Specific Health Guidance Program and the MOTHER Bracelet for fitness and health applications.
  • MEDIROM is planning to acquire 70% of Japan Gene Medicine Corporation to expand its presence in the healthcare technology space.
  • The company faces risks related to achieving development goals, economic conditions, competition, and regulatory changes.

Sentiment

Score: 6

Explanation: The document presents a mixed outlook. While there are positives such as brand value and expansion plans, there are also significant risks and challenges, including financial performance concerns and potential delays. The sentiment is cautiously optimistic.

Positives

  • The company has a strong brand value and a loyal customer base.
  • MEDIROM owns one of the largest education and training facilities for relaxation therapists in Japan.
  • The company has a strong position for continued growth in the Specific Health Guidance Program.
  • The MOTHER Bracelet is a unique fitness tracker that requires no electric charging.
  • The company is actively working to optimize its workforce and improve profitability.
  • The company is actively working to expand its business in the Kansai region in western Japan.

Negatives

  • The company's system-wide relaxation salon base is geographically concentrated in the Tokyo metropolitan area.
  • The Digital Preventative Healthcare Segment may not continue to grow as intended or achieve sustained profitability.
  • The company may face labor shortages or increased labor costs.
  • The company is exposed to the risk of natural disasters and global pandemics.
  • The company may be delayed in complying with its periodic reporting obligations under the Exchange Act.

Risks

  • The company may not achieve its development goals, which could adversely affect operations and financial results.
  • Japanese and global economic conditions and financial markets may deteriorate.
  • The planned acquisition of Japan Gene Medicine Corporation may not be completed.
  • The company's level of indebtedness could materially and adversely affect its business.
  • The company is vulnerable to changes in consumer preferences and economic conditions.
  • Information technology system failures or breaches of network security could interrupt operations.
  • The company's Chief Executive Officer owns a golden share with key veto rights, thereby limiting a shareholders ability to influence the business and affairs.

Future Outlook

MEDIROM intends to continue expanding its business through new salon openings, acquisitions, and strategic investments, with a focus on both the Japanese market and potential overseas expansion. The company also plans to invest in and grow its Digital Preventative Healthcare Segment and increase the segments profit margin.

Industry Context

The Japanese relaxation sector is experiencing consolidation, with market share shifting to category leaders. There is also increasing interest in employee wellness programs, which is expected to drive demand for MEDIROM's services.

Comparison to Industry Standards

  • According to the 2022 Yano Report, MEDIROM is one of the top three companies in the Kanto region and in the top four nationwide in terms of the number of salons.
  • The largest operator in the Japanese relaxation sector has 613 salons, while MEDIROM aims to operate 500 salons by 2028.
  • The Japanese NIPT market is estimated to grow at an average rate of approximately 8% per year from 2025 to 2037.

Related Party Transactions

  • Kouji Eguchi, our Chief Executive Officer, is a guarantor for 5 bank loans on behalf of our Company.
  • Tomoya Ogawa, an independent director of our Company, is the sole owner of Kabushiki Kaisha LTW, a Japanese company that received consulting fees from our Company.
  • Akira Nojima, an independent director of our Company, is the sole owner of Kabushiki Kaisha No Track, a Japanese company that received consulting fees from our Company.
  • Osamu Sato, a corporate auditor of our Company, is a part-time employee of Ebis 20 Co., Ltd., a Japanese company that received consulting fees from our Company.
  • Mr. Kazuyoshi Takahashi, the representative director of ZACC, is the guarantor for three bank loans on behalf of ZACC.

Stakeholder Impact

  • Shareholders may experience dilution from the issuance of new shares.
  • Employees may be affected by the workforce optimization strategies.
  • Customers may benefit from the expansion of services and improved quality.
  • Franchisees may be affected by changes in the franchise model and operational standards.
  • Suppliers and creditors may be impacted by the company's financial performance and ability to meet obligations.

Next Steps

  • Complete the proposed public offering of American Depositary Shares (ADS).
  • Negotiate and secure financing for the planned acquisition of 70% of Japan Gene Medicine Corporation.
  • Continue to implement workforce optimization strategies to improve margins.
  • Expand the Digital Preventative Healthcare Segment and increase its profit margin.
  • Monitor and address any potential risks related to economic conditions, competition, and regulatory changes.

Key Dates

DateDescription
July 13, 2000MEDIROM Healthcare Technologies Inc. was originally incorporated as Kabushiki Kaisha Young Leaves.
December 1, 2008MEDIROM began issuing prepaid cards called Re.Ra.Ku Cards to relaxation salon customers.
April 2008The Japanese government initiated the Specific Health Guidance Program.
October 1, 2021MEDIROM acquired a 60% ownership interest in ZACC Kabushiki Kaisha.
January 2022MEDIROM acquired the remaining 40% interest in ZACC Kabushiki Kaisha.
December 2022MEDIROM issued corporate convertible bonds to Kufu Company Inc.
July 3, 2023MEDIROM transferred its Digital Preventative Healthcare business to MEDIROM MOTHER Labs Inc.
February 1, 2024MEDIROM disallowed further balance deposits on Re.Ra.Ku Cards and launched Re.Ra.Ku PAY.
June 30, 2024MEDIROM signed an agreement to acquire 70% of Japan Gene Medicine Corporation.
August 7, 2024MEDIROM MOTHER Labs Inc. entered into a capital and business alliance with NFES Technologies Inc.

Keywords

relaxation salons, healthcare technology, digital preventative healthcare, franchise, ADS offering, MEDIROM, Japan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.